Cargando…

A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors

Clinically aggressive disease behavior is difficult to predict in men with low to intermediate clinical risk prostate cancer and methylation biomarkers may be a valuable adjunct for assessing the management of these patients. We set to evaluate the utility of DNA methylation to identify high risk di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmad, Amar S., Vasiljević, Nataša, Carter, Paul, Berney, Daniel M, Møller, Henrik, Foster, Christopher S., Cuzick, Jack, Lorincz, Attila T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342126/ https://www.ncbi.nlm.nih.gov/pubmed/27708246 http://dx.doi.org/10.18632/oncotarget.12377

Ejemplares similares

DNA methylation gene-based models indicating independent poor outcome in prostate cancer
por: Vasiljević, Nataša, et al.
Publicado: (2014)

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer
por: Vasiljević, N, et al.
Publicado: (2013)

A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers()
por: Vasiljević, Nataša, et al.
Publicado: (2014)

Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women
por: Vasiljević, Nataša, et al.
Publicado: (2014)

Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions
por: Lorincz, Attila T., et al.
Publicado: (2017)

A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
por: Brentnall, Adam R, et al.
Publicado: (2014)

Validation of a DNA methylation HPV triage classifier in a screening sample
por: Lorincz, Attila T., et al.
Publicado: (2016)

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

Role of quantitative p16(INK4A) mRNA assay and digital reading of p16(INK4A) immunostained sections in diagnosis of cervical intraepithelial neoplasia
por: Vasiljević, Nataša, et al.
Publicado: (2017)

Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy
por: Cuzick, Jack M., et al.
Publicado: (2021)

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology
por: Lorincz, Attila T, et al.
Publicado: (2013)

Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
por: Berney, Daniel M, et al.
Publicado: (2016)

Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Consistency of the S5 DNA methylation classifier in formalin‐fixed biopsies versus corresponding exfoliated cells for the detection of pre‐cancerous cervical lesions
por: Reuter, Caroline, et al.
Publicado: (2021)

Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively
por: Ahmad, Amar S., et al.
Publicado: (2018)

Absolute Quantitation of DNA Methylation of 28 Candidate Genes in Prostate Cancer Using Pyrosequencing
por: Vasiljeviš, Nataڑa, et al.
Publicado: (2011)

Molecular progression to cervical precancer, epigenetic switch or sequential model?
por: Nedjai, Belinda, et al.
Publicado: (2018)

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015)

DNA methylation testing with S5 for triage of high‐risk HPV positive women
por: Adcock, Rachael, et al.
Publicado: (2022)

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2012)

Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
por: Hieronymus, Haley, et al.
Publicado: (2018)

Cancer diagnostic classifiers based on quantitative DNA methylation
por: Lorincz, Attila T
Publicado: (2014)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

NKAIN2 functions as a novel tumor suppressor in prostate cancer
por: Mao, Xueying, et al.
Publicado: (2016)

The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2017)

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
por: Berney, D M, et al.
Publicado: (2009)

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
por: Reid, A H M, et al.
Publicado: (2010)

The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer
por: Helfand, Brian T., et al.
Publicado: (2022)

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
por: Cook, Darrel A., et al.
Publicado: (2018)

Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study
por: Roychoudhuri, Rahul, et al.
Publicado: (2007)

Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping
por: Hernández-López, Rubí, et al.
Publicado: (2019)

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
por: Foster, C S, et al.
Publicado: (2009)

Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)
por: Leapman, Michael S., et al.
Publicado: (2017)

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men
por: Shaw, G L, et al.
Publicado: (2014)

Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’
por: Berney, Daniel M
Publicado: (2017)

No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
por: Cyll, Karolina, et al.
Publicado: (2022)

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
por: Merson, S, et al.
Publicado: (2014)

Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing
por: Dinneen, Eoin, et al.
Publicado: (2022)

Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer
por: Stankiewicz, Elzbieta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jghk00bp8ft7g5pc61qt7skfkb